Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma
Christopher A. Carter, Charles Chen, Cheryl Brink, Patrick Vincent, Yulia Y. Maxuitenko, Karen S. Gilbert, William R. Waud, Xiaomei ZhangVolume:
59
Language:
english
Pages:
13
DOI:
10.1007/s00280-006-0257-y
Date:
February, 2007
File:
PDF, 468 KB
english, 2007